Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

Kloppenburg, Margreet ; Peterfy, Charles ; Haugen, Ida K ; Kroon, Féline ; Chen, Su ; Wang, Li ; Liu, Wei ; Levy, Gwen ; Fleischmann, Roy M ; Berenbaum, Francis ; van der Heijde, Désirée ; Bansal, Prashant ; Wittoek, Ruth ; Feng, Sheng ; Fang, Yuni ; Saltarelli, Mary ; Medema, Jeroen K ; Levesque, Marc C

Annals of the rheumatic diseases, 2019-03, Vol.78 (3), p.413-420 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível